Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  New Frontier Health Corporation    NFH   KYG6461G1064

NEW FRONTIER HEALTH CORPORATION

(NFH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Sector Healthcare Facilities & Services - NEC
1st jan.Capitalisation (M$)Investor Rating
NEW FRONTIER HEALTH CORPORA..-12.90%1 144
-
CVS HEALTH CORPORATION-10.11%86 899
HCA HEALTHCARE, INC.1.08%49 856
FRESENIUS MEDICAL CARE AG &..7.64%24 755
LABORATORY CORPORATION OF A..17.26%19 746
QUEST DIAGNOSTICS16.87%16 820
PING AN HEALTHCARE AND TECH..74.14%14 992
DAVITA INC.46.63%12 303
UNIVERSAL HEALTH SERVICES-8.53%11 130
CHEMED CORPORATION8.62%7 858
ENCOMPASS HEALTH CORPORATIO..16.47%7 839
MEINIAN ONEHEALTH HEALTHCAR..-21.09%7 095
WINNING HEALTH TECHNOLOGY G..44.84%5 377
RYMAN HEALTHCARE LIMITED-10.04%5 228
JINXIN FERTILITY GROUP LIMI..24.76%4 133
ACADIA HEALTHCARE COMPANY, ..32.00%3 836
More Results
Financials
Sales 2019 2 500 M 380 M 380 M
Net income 2019 - - -
Net Debt 2019 - - -
P/E ratio 2019 -11,1x
Yield 2019 -
Capitalization 7 509 M 1 144 M 1 141 M
Capi. / Sales 2019 3,00x
Capi. / Sales 2020 3,07x
Nbr of Employees -
Free-Float 81,2%
Upcoming event on NEW FRONTIER HEALTH CORPORATION
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances -
Profitability -
Earnings quality -
Business Predictability -
P/E ratio -
Potential
Yield -
Consensus -
7 days EPS revision
4 months EPS revision
1 year EPS revision -
4 months Revenue revision
1 year Revenue revision -
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes